Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-04-23 | Stephen Davis has served as a director of Heron since October 2019. ... The Audit Committee is composed of three directors: Messrs. Davis, Johnson and Waage. ... The Compensation Committee is composed of three directors: Messrs. Davis, Johnson and Tang. ... The following table includes compensation for services provided by our non-employee directors for the year ended December 31, 2019: ... Stephen Davis was appointed to the board in October 2019. ... Option Awards: $498,773 Fees Earned or Paid in Cash: $12,500 Total: $511,273. |
| 2021-04-22 | Stephen Davis has served as a director of Heron since 2019. Mr. Davis has served as Chief Executive Officer and as a director of ACADIA Pharmaceuticals Inc. since 2015 and, previously, as Executive Vice President, Chief Financial Officer and Chief Business Officer from 2014 to 2015. |
| 2022-04-25 | Stephen Davis has served as a director of Heron since 2019. The Board has determined that Mr. Davis should serve as a director based on his experience in senior management, as a director with other biotechnology and pharmaceutical companies and in legal, finance and operations matters. |
| Filing Date | Source Excerpt |
|---|---|
| 2010-08-06 | Stephen Davis (58). Managing Member, Davis Investigative Group, LLC |
| 2011-08-19 | Stephen Davis (59). Managing Member, Davis Investigative Group, LLC since 2001. Mr. Davis served as a senior officer in the New York City Police Department and has successfully managed his own business servicing the financial services industry and other clients for more than 10 years. |
| 2012-08-16 | Stephen Davis (60). Managing Member, Davis Investigative Group, LLC since 2001. Mr. Davis served as a senior officer in the New York City Police Department and has successfully managed his own business servicing the financial services industry and other clients for more than 10 years. |
Data sourced from SEC filings. Last updated: 2025-10-12